Phibro Animal Health reported $176.84M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Align Technology ALGN:US $ 281.99M 18.12M
Ani Pharmaceuticals ANIP:US $ 35.29M 1.02M
Aurora Cannabis Inc ACB:CN 72.46M 30.9M
Bristol Myers Squibb BMY:US $ 2677M 206M
Canopy Growth Corp WEED:CN C$ 111.51M 159.5M
Corcept Therapeutics CORT:US $ 1.32M 0.07M
Depomed DEPO:US $ 4.53M 0.73M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Endo International Ordinary Shares ENDP:US $ 263.79M 84.03M
Henry Schein HSIC:US $ 2085M 121M
Idexx Laboratories IDXX:US $ 346.51M 8.72M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Knight Therapeutics Inc GUD:CN C$ 37.52M 6.19M
Lannett LCI:US $ 66.33M 8.95M
Merk MRK:US $ 3698M 1636M
Nektar Therapeutics NKTR:US $ 5.12M 0.2M
Pacira Pharmaceuticals PCRX:US $ 50.63M 14.55M
Patterson Companies PDCO:US $ 1211.13M 79.4M
Phibro Animal Health PAHC:US $ 176.84M 8.85M
Prestige Brands PBH:US $ 116.94M 1.13M
Supernus Pharmaceuticals SUPN:US $ 20.46M 2.52M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M
Zoetis ZTS:US $ 620M 55M